---
title: "Research Overview: Dermorphin"
subtitle: "A comprehensive laboratory research guide to Dermorphin, a heptapeptide opioid peptide isolated from frog skin for opioid receptor activation, analgesic mechanisms, pain modulation, and neurotransmitter function research"
author: "Vici Peptides Editorial"
publishedDate: "2025-01-XX"
category: "Mental / Neurological / Sleep"
keywords: ["Dermorphin", "D-Ala2-Dermorphin", "Frog skin peptide", "dermorphin", "opioid peptide", "opioid receptor activation", "analgesic mechanisms", "pain modulation", "neurotransmitter function", "pain-related disorders", "opioid receptor binding", "pain research", "receptor research", "laboratory research", "mechanism of action", "C40H50N8O10", "heptapeptide", "opioid", "neurological research"]
relatedProductSlug: "dermorphin-5mg"
---

import { ArticleImage } from '@/components/blog/ArticleImage';

# Research Overview: Dermorphin

> A comprehensive laboratory research guide to Dermorphin, a heptapeptide opioid peptide isolated from frog skin for opioid receptor activation, analgesic mechanisms, pain modulation, and neurotransmitter function research

## Table of Contents

- [Introduction](#introduction)
- [Mechanism of Action](#mechanism-of-action)
- [Chemical Background](#chemical-background)
- [Laboratory Applications](#laboratory-applications)
- [Handling and Storage Guidelines](#handling-storage)

## Introduction

Dermorphin, also known as D-Ala2-Dermorphin or Frog skin peptide, represents a heptapeptide opioid peptide that has been extensively studied for its potential effects on opioid receptor activation and pain modulation. This peptide has been investigated for its ability to influence opioid receptor binding, analgesic mechanisms, pain modulation, and neurotransmitter function in experimental models. Laboratory researchers utilize Dermorphin to investigate opioid receptor activation, opioid receptor binding, analgesic mechanisms, pain modulation, neurotransmitter function, and pain-related disorders in experimental models. The compound falls within the Mental / Neurological / Sleep category and serves as a valuable research tool for understanding opioid receptor function and pain mechanisms.

Dermorphin is used in laboratory research to investigate opioid receptor activation. Research applications include studies on opioid receptor binding, analgesic mechanisms, pain modulation, neurotransmitter function, and pain-related disorders in experimental models. The compound has been investigated for its potential role in modulating opioid receptor function, influencing pain perception, and affecting analgesic mechanisms. These investigations contribute to the broader understanding of Dermorphin mechanisms and may inform future research directions in opioid receptor and pain research.

The heptapeptide opioid peptide has been studied extensively in laboratory settings for its effects on opioid receptors and pain pathways. Researchers investigate Dermorphin to understand how this compound may influence opioid receptor binding, analgesic mechanisms, pain modulation, neurotransmitter function, and pain-related disorders. These studies contribute to understanding Dermorphin mechanisms and may provide insights into opioid receptor and pain research applications.

## Mechanism of Action

Dermorphin functions through interactions with opioid receptors in the central nervous system and peripheral tissues. The compound's mechanism of action involves opioid receptor activation, analgesic mechanism activation, pain modulation activation, neurotransmitter function activation, and pain-related disorder research applications. Understanding these mechanisms is essential for laboratory researchers investigating opioid receptor function and pain mechanisms.

One of the primary mechanisms involves opioid receptor activation. Dermorphin has been shown to bind to and activate mu-opioid receptors, delta-opioid receptors, and kappa-opioid receptors through effects on opioid-regulating brain regions. The compound may activate opioid-promoting mechanisms, including effects on the periaqueductal gray, spinal cord, and other opioid-regulating centers. This mechanism is particularly relevant for research into opioid receptor function and pain modulation. Laboratory studies investigate how Dermorphin may influence opioid receptor binding and opioid receptor function.

The compound also influences analgesic mechanisms through effects on pain pathways and pain perception. Dermorphin has been shown in laboratory studies to modulate pain responses, reduce pain sensitivity, and influence pain thresholds through effects on pain-regulating systems. The compound may affect analgesic mechanism pathways, including effects on descending pain inhibition, spinal cord pain processing, and supraspinal pain modulation. Laboratory researchers investigate how the compound may influence analgesic mechanisms and pain function.

Pain modulation involves effects on pain perception and pain processing pathways. Dermorphin has been shown in laboratory studies to modulate pain responses, influence pain thresholds, and affect pain-related behaviors through effects on pain-regulating systems. The compound may affect pain modulation pathways, including effects on nociceptive processing, pain transmission, and pain inhibition. Laboratory researchers investigate how Dermorphin may influence pain modulation and pain function.

Neurotransmitter function activation involves effects on neurotransmitter release and function in pain pathways. Dermorphin may influence the release and function of various neurotransmitters that regulate pain perception and opioid receptor function. The compound may affect neurotransmitter signaling pathways and downstream effects on pain processing and opioid receptor activation. Laboratory researchers investigate how Dermorphin may influence neurotransmitter function and pain-related neurotransmitter systems.

Pain-related disorder research involves investigations into the effects of Dermorphin on various pain conditions. Dermorphin has been studied for its potential role in chronic pain, neuropathic pain, inflammatory pain, and other pain-related disorders. The compound may be used to investigate mechanisms underlying pain-related disorders and their effects on opioid receptor function and pain pathways. Laboratory researchers investigate how Dermorphin may influence pain-related disorders and their treatment.

The stability of Dermorphin (shelf life: 36 months) is an important consideration for laboratory research. Proper storage and handling are essential to maintain the compound's biological activity and structural integrity throughout experimental procedures. Researchers typically assess the compound's stability under various conditions, including temperature, pH, light exposure, and storage duration, to ensure reliable experimental results.

Laboratory researchers investigate several specific mechanisms through which Dermorphin may influence opioid receptor function and pain mechanisms:

- **Opioid receptor activation**: The compound binds to and activates opioid receptors through effects on opioid-regulating brain regions
- **Analgesic mechanism activation**: Dermorphin may modulate pain responses through effects on pain-regulating systems
- **Pain modulation activation**: The compound may influence pain perception through effects on pain-processing pathways
- **Neurotransmitter function activation**: Dermorphin may affect neurotransmitter release and function in pain pathways
- **Pain-related disorder research**: The compound may be used to investigate pain-related disorders and their mechanisms
- **Mu-opioid receptor binding**: Dermorphin may bind to and activate mu-opioid receptors
- **Delta-opioid receptor binding**: The compound may interact with delta-opioid receptors
- **Kappa-opioid receptor binding**: Dermorphin may affect kappa-opioid receptor function
- **Descending pain inhibition**: The compound may activate descending pain inhibitory pathways
- **Spinal cord pain processing**: Dermorphin may influence pain processing in the spinal cord

The biological function of Dermorphin in research contexts involves its interaction with cellular targets related to opioid receptor function and pain mechanisms. Laboratory studies have investigated the compound's effects on opioid receptor binding, analgesic mechanisms, pain modulation, neurotransmitter function, and pain-related disorders. Understanding these interactions helps researchers design experiments to investigate specific biological processes and pathways related to opioid receptor function and pain mechanisms.

## Chemical Background

Dermorphin has the chemical formula C40H50N8O10 with a molar mass of 802.9 g/mol. The compound is a heptapeptide opioid peptide with specific structural characteristics. The CAS registry number is 77614-16-5. The compound is also known by the following synonyms: Dermorphin, D-Ala2-Dermorphin, Frog skin peptide. Additional chemical information can be found in PubChem (ID: 16129809). The structural properties of Dermorphin contribute to its biological activity and research applications.

Dermorphin is a heptapeptide opioid peptide that has been designed to activate opioid receptor-regulating mechanisms and produce opioid receptor function and analgesic effects. The compound's structure, including its heptapeptide nature and opioid peptide properties, allows it to bind to various opioid receptors and produce opioid receptor-regulating effects. The synthetic nature of Dermorphin ensures consistent quality and purity for laboratory research applications.

The structural characteristics of Dermorphin allow it to function as an opioid receptor-regulating peptide with specific biological activity. The compound's ability to bind to and activate opioid receptor-regulating mechanisms, combined with its opioid receptor function and analgesic properties, makes it valuable for research into opioid receptor binding, analgesic mechanisms, pain modulation, and neurotransmitter function. The compound's specific structure, including its heptapeptide nature and opioid peptide properties, ensures consistent biological activity and research reproducibility.

## Laboratory Applications

Dermorphin is used in laboratory research to investigate opioid receptor activation. Research applications include studies on opioid receptor binding, analgesic mechanisms, pain modulation, neurotransmitter function, and pain-related disorders in experimental models.

Researchers typically employ Dermorphin in in vitro cell culture studies, ex vivo tissue experiments, and whole-animal models to understand its effects on cellular mechanisms, opioid receptor function, and pain outcomes. The compound's lab-handling relevance is significant, as proper preparation, storage, and administration protocols are essential for obtaining reliable and reproducible research results.

In vitro applications of Dermorphin involve studies conducted in controlled laboratory environments using cell cultures, tissue samples, or isolated biological systems. These studies allow researchers to investigate the compound's effects on specific cellular processes, including:

- **Opioid receptor binding assays**: Measuring binding affinity and activation of opioid-regulating receptors in cell cultures
- **Analgesic mechanism studies**: Investigating effects on pain pathways and pain processing in cell cultures
- **Pain modulation assays**: Studying effects on pain perception and pain thresholds in cell cultures
- **Signal transduction pathway analysis**: Studying activation of opioid receptor-regulating signaling pathways and downstream signaling cascades
- **Gene expression studies**: Measuring effects on opioid-related gene expression and pain-related gene expression
- **Neurotransmitter release assays**: Studying effects on neurotransmitter release and function in pain pathways
- **Receptor expression profiling**: Measuring effects on opioid receptor expression and distribution
- **Cellular signaling pathway analysis**: Studying effects on intracellular signaling pathways related to opioid receptor function and pain mechanisms
- **Pain threshold assays**: Investigating effects on pain sensitivity and pain thresholds in cell cultures
- **Opioid receptor subtype studies**: Studying effects on different opioid receptor subtypes and their functions

Ex vivo applications involve experiments conducted on tissues or organs removed from their natural biological environment but maintained in conditions that preserve their biological activity. These studies provide insights into how Dermorphin interacts with intact biological systems while maintaining experimental control. Research applications include:

- **Brain tissue studies**: Investigating effects on opioid receptor function, pain pathways, and neurotransmitter function in intact brain tissue
- **Spinal cord tissue studies**: Studying effects on pain processing, opioid receptor binding, and analgesic mechanisms in intact spinal cord tissue
- **Pain-regulating tissue models**: Studying effects on pain perception and pain processing in intact tissue systems
- **Opioid receptor tissue models**: Investigating effects on opioid receptor function and binding in various tissue types

Whole-animal applications involve studies conducted in animal models to investigate the compound's effects on opioid receptor function, pain mechanisms, and overall pain-related behaviors. These studies allow researchers to understand how Dermorphin influences complex physiological outcomes and pain-related behaviors. Research applications include:

- **Opioid receptor function studies**: Investigating effects on opioid receptor binding and opioid receptor function in animal models
- **Pain mechanism studies**: Studying effects on pain perception, pain thresholds, and pain-related behaviors
- **Analgesic effect studies**: Investigating effects on pain responses and analgesic mechanisms in animal models
- **Pain-related disorder studies**: Investigating effects on chronic pain, neuropathic pain, and inflammatory pain in animal models

Researchers working with Dermorphin should follow established laboratory protocols, maintain sterile conditions during reconstitution and handling, and adhere to all safety guidelines. Proper documentation of experimental procedures, storage conditions, and handling protocols is essential for research reproducibility and scientific rigor.

## Handling and Storage Guidelines

Storage Requirements: Store lyophilized powder at -20°C in a dry environment. Protect from light and moisture. Reconstituted solution should be stored at 4°C for up to 14 days. Maintain sterile conditions during reconstitution.

Handling Guidelines: Handle using sterile techniques and appropriate laboratory personal protective equipment (PPE). Use in well-ventilated areas. Avoid inhalation, ingestion, or skin contact. Follow standard laboratory safety protocols. Refer to Material Safety Data Sheet (MSDS) for complete safety information.

Shelf Life: 36 months when stored properly as lyophilized powder under recommended conditions (-20°C, dry environment, protected from light and moisture).

Reconstitution Notes: When reconstituting Dermorphin, use sterile water or appropriate buffer solutions. Maintain sterile conditions throughout the reconstitution process. Store reconstituted solutions at 4°C and use within 14 days. Avoid repeated freeze-thaw cycles, as this may affect compound stability and biological activity.

Temperature Sensitivity: Dermorphin should be stored at -20°C to maintain compound stability and biological activity. Avoid exposure to higher temperatures that could degrade the compound or reduce its biological activity. When working with the compound, minimize time at room temperature and return to appropriate storage conditions promptly.

Light Sensitivity: Dermorphin should be protected from direct light exposure. Use appropriate containers or work in dim light conditions when handling the compound. Protect both lyophilized powder and reconstituted solutions from light exposure to maintain biological activity.

## Cross-Linked Research

Related research peptides in the same category:

- [Melatonin](/blog/melatonin-10mg)
- [DSIP](/blog/dsip-5mg)
- [Semax](/blog/semax)
- [Selank](/blog/selank)

## External Citations

Reference authoritative research sources:

- [Dermorphin - PubChem Compound Summary](https://pubchem.ncbi.nlm.nih.gov/compound/16129809) (PubChem (NCBI))
- [PubMed Search: Dermorphin Research Literature](https://pubmed.ncbi.nlm.nih.gov/?term=Dermorphin) (PubMed (NCBI))
- [PubMed Search: Opioid Receptor Research](https://pubmed.ncbi.nlm.nih.gov/?term=opioid+receptor) (PubMed (NCBI))
- [PubMed Search: Analgesic Mechanisms Research](https://pubmed.ncbi.nlm.nih.gov/?term=analgesic+mechanisms) (PubMed (NCBI))
- [CAS Registry: Dermorphin (77614-16-5)](https://commonchemistry.cas.org/detail?cas_rn=77614-16-5) (CAS Registry)
- [Dermorphin - Chemical Information Database](https://www.ncbi.nlm.nih.gov/) (NCBI)

## References

- National Center for Biotechnology Information. PubChem Compound Summary for CID 16129809, Dermorphin. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/16129809
- Chemical Abstracts Service. CAS Registry Number 77614-16-5 - Dermorphin. CAS Registry. https://commonchemistry.cas.org/detail?cas_rn=77614-16-5
- PubMed. Search results for "Dermorphin" in research literature. National Library of Medicine. https://pubmed.ncbi.nlm.nih.gov/?term=Dermorphin
- PubMed. Search results for "opioid receptor" in research literature. National Library of Medicine. https://pubmed.ncbi.nlm.nih.gov/?term=opioid+receptor
- PubMed. Search results for "analgesic mechanisms" in research literature. National Library of Medicine. https://pubmed.ncbi.nlm.nih.gov/?term=analgesic+mechanisms
- Chemical Formula: C40H50N8O10
- Molar Mass: 802.9 g/mol
- CAS Number: 77614-16-5
- Synonyms: Dermorphin, D-Ala2-Dermorphin, Frog skin peptide

---

## Research Use Only Disclaimer

<div className="p-6 bg-red-900/30 border-l-4 border-red-500 rounded">
  <h3 className="text-heading text-lg font-semibold text-red-400 mb-2">
    Research Use Only Disclaimer
  </h3>
  <div className="text-sm text-red-300 whitespace-pre-line">
    All materials are sold strictly for laboratory research use only. Not for human administration.
  </div>
</div>

---

## Related Product

[View Dermorphin Product Page](/products/dermorphin-5mg)

